Compare VMO & AVNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VMO | AVNS |
|---|---|---|
| Founded | 1992 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 652.2M | 521.7M |
| IPO Year | N/A | N/A |
| Metric | VMO | AVNS |
|---|---|---|
| Price | $9.53 | $11.35 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 254.7K | ★ 562.3K |
| Earning Date | 01-01-0001 | 11-05-2025 |
| Dividend Yield | ★ 4.39% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $699,900,000.00 |
| Revenue This Year | N/A | $3.07 |
| Revenue Next Year | N/A | $2.16 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 2.70 |
| 52 Week Low | $7.86 | $9.30 |
| 52 Week High | $9.87 | $19.91 |
| Indicator | VMO | AVNS |
|---|---|---|
| Relative Strength Index (RSI) | 40.70 | 47.53 |
| Support Level | $9.47 | $10.84 |
| Resistance Level | $9.78 | $12.34 |
| Average True Range (ATR) | 0.07 | 0.46 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 23.81 | 34.00 |
Invesco Municipal Opportunity Trust is a diversified, closed-end management investment company. The investment objective of the company is to provide common shareholders with a high level of current income exempt from federal income tax, consistent with preservation of capital.
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.